Precision Optics Corporation, Inc. Raises $1.0 Million in Private Placement

Precision Optics Corporatin


Share Tweet

Precision Optics Corporation, Inc. Raises $1.0 Million in Private Placement

GARDNER, MA / ACCESSWIRE / July 8, 2014 / Precision Optics Corporation, Inc. (OTCQB: PEYE) (the "Company") announced today that it has entered into definitive agreements with institutional and accredited investors for the sale and purchase of 1,717,152 shares of common stock at $0.60 per share.

The Company has received $1,030,291 in gross proceeds from the offering. The offering closed on July 7, 2014. Net proceeds from the offering will be used for working capital needs and for general corporate purposes.

The lead investor in the financing was Hershey Strategic Capital, LP.  Managing Member, Adam Hershey, commented "We are happy to lead this round of financing at a time when I believe Precision Optics is at an inflection point, and well positioned for future profitable growth.  I am excited to work with the Company’s Board and Management to help realize the Company’s full potential."  Joe Forkey, Company President and CEO, commented, "We are pleased to have Hershey Strategic Capital as a new investor in the Company.  We look forward to working with them to continue the Company’s recent trend of increasing revenues and to pursue opportunities in the medical device market made possible by Precision Optics' proprietary technology."

This press release is neither an offer to sell, nor a solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.

About Precision Optics Corporation 
Precision Optics Corporation has been a leading developer and manufacturer of advanced optical instruments since 1982.  The Company designs and produces next generation medical instruments, Microprecision(TM) micro-optics with characteristic dimensions less than 1 millimeter, and other advanced optical systems based on the Company’s state-of-the-art optical technologies. The Company’s innovative medical instrumentation line includes Lenslock(TM) laparoscopes, arthroscopes, and sinuscopes, as well as endocouplers and a world-class product line of 3D endoscopes for use in minimally invasive surgical procedures. The Company’s website is Investors can find Real-Time quotes and market information for the Company on

About Forward-Looking Statements 
This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements related to our future activities or future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by our management. These statements are not guarantees of future performances and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors, including those risks discussed in our annual report on Form 10-K and in other documents that we file from time to time with the SEC. Any forward-looking statements speak only as of the date on which they are made, and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this report, except as required by law.

SOURCE: Precision Optics Corporation, Inc.